Floating Button
Home Capital Broker's Calls

Manulife US REIT taking the 'right measures' after 10% fall in valuation: analysts

Jovi Ho
Jovi Ho • 5 min read
Manulife US REIT taking the 'right measures' after 10% fall in valuation: analysts
CGS-CIMB Research analysts have cut their target price for Manulife US REIT following its FY2022 results. Photo: Bloomberg
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

Analysts are remaining positive on Manulife US REIT (MUST) (SGX:BTOU) after the REIT’s FY2022 results.

To RHB Group Research analyst Vijay Natarajan, the REIT is taking the right measures to rein in elevated gearing amid a decline in valuations.

MUST reported FY2022 ended December results on Feb 9, with distribution per unit (DPU) of 2.14 US cents (2.835 cents) for the 2HFY2022 ended Dec 31, 2022, 18.6% lower than the DPU of 2.63 US cents reported in the 2HFY2021.

×
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2026 The Edge Publishing Pte Ltd. All rights reserved.